Wajeeha Razaq, MD

  • Primary Specialty: Hematology & Oncology
  • Languages Spoken: English
  • Practice Started: 1/1/2008
  • Gender: Female

About Wajeeha Razaq

Wajeeha Razaq, MD joined the Hematology/Oncology department in 2012 and serves as the site chair for breast cancer. She works closely with campus education efforts by coordinating rotations for medical students and is chair of the Clinical Competency Committee for the Hematology/Oncology Fellowship Program.

Dr. Razaq’s research interests are concentrated on locally advanced and metastatic breast cancer in addition to the breast malignancy phase I program at the Stephenson Cancer Center. She is an investigator on many clinical and phase I trials conducted on campus. Dr. Razaq has also published many articles and abstracts on the subject of breast cancer.

She serves on the Breast Administrative Committee that provides oversight to the clinical care process from diagnosis to survivorship. Dr. Razaq completed her residency at SUNY Downstate Long Island College Hospital and her fellowship in Hematology/Oncology at Mount Sinai Roosevelt Hospital in New York. She is board certified in internal medicine and medical oncology.

Affiliations OU Health Stephenson Cancer Center – Breast Cancer Clinic, OU Health Stephenson Cancer Center
  • Merit Scholarship in Medical College
  • Award for Best Research Paper (LICH, NY) 2004
  • Quaid-e Azam Scholarship in Medical College
Health Education
  • Medical School
  • Medical Degree King Edward Medical College
  • Fellowship
  • St. Luke’s Roosevelt Hospital Center
    New York, NY
  • Residency
  • Pediatrics Mayo Clinic
    Lahore Pakistan2000
  • Internal Medicine Sunny Downstate Long Island College Hospital
    Brooklyn, NY
  • College
  • BS King Edward Medical University
    Lahore, Pakistan1997
  • Fellowship
  • Hematology/Oncology Mount Sinai Roosevelt Hospital
    New York City, NY
  • Board Certification
  • Internal Medicine 2005
  • Medical Oncology 2008
Medical Interests Areas of Interest:
  • Breast Cancer
  • Systemic therapy for metastatic GE junction tumors
  • Systemic therapy for hepatoma
  • Neo-adjuvant therapy for breast cancer
Star Ratings